Retrospective Analysis of R-COMP Therapy in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Assessing the Impact of Sample Selection Bias.

MLA

Romano, Chiara, et al. “Retrospective Analysis of R-COMP Therapy in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Assessing the Impact of Sample Selection Bias.” Journal of Clinical Medicine, vol. 14, no. 2, Jan. 2025, p. 639. EBSCOhost, https://doi.org/10.3390/jcm14020639.

APA

Romano, C., Branda, F., Petrosillo, N., Arcari, A., Merli, F., Spina, M., Ceccarelli, G., Ciccozzi, M., Scarpa, F., & Rigacci, L. (2025). Retrospective Analysis of R-COMP Therapy in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Assessing the Impact of Sample Selection Bias. Journal of Clinical Medicine, 14(2), 639. https://doi.org/10.3390/jcm14020639

Chicago

Romano, Chiara, Francesco Branda, Nicola Petrosillo, Annalisa Arcari, Francesco Merli, Michele Spina, Giancarlo Ceccarelli, Massimo Ciccozzi, Fabio Scarpa, and Luigi Rigacci. 2025. “Retrospective Analysis of R-COMP Therapy in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Assessing the Impact of Sample Selection Bias.” Journal of Clinical Medicine 14 (2): 639. doi:10.3390/jcm14020639.